The document discusses 10 common myths about Canada's SR&ED (Scientific Research and Exploratory Development) tax credit program. It aims to clarify that 1) companies do not need to reveal proprietary secrets when filing claims, 2) processing times have improved to around 4 months, and 3) projects do not need to be in science/technology to qualify as long as they involve technological advancement. The document provides examples to address each myth and encourage more companies to take advantage of the significant tax credits available through the program.
In Canada, tax is paid at both federal and provincial (i.e. state) levels of government.
Both the federal government and most provincial governments provide funding for scientific and technological R&D through a system of tax credits.
The official title of this system of R&D tax credits is the Scientific Research & Experimental Development tax credit abbreviated SR&ED.
The SR&ED program is administrated by the Canada Revenue Agency abbreviated CRA.
All taxpayers anywhere in Canada are eligible to receive R&D tax credits at the federal level. Eligibility for R&D tax credits at the provincial level is predicated on two considerations; First the province must have an R&D credit and second, you must be a taxpayer in that province.
In addition to being done by a Canadian taxpayer, the R&D work must be done in Canada.
Marpai is an AI tech company revolutionizing the self-funded health plan
market representing over $1 trillion in health claims, $20 billion in
administrative fees, and 95 million Americans. Just as Netflix, Amazon,
Uber, and Tesla use artificial intelligence to transform and lead industry
sectors, Marpai (pronounced Mar-pay) is using deep learning, the most
advanced artificial intelligence, to transform health plan administration
for companies who self-fund their health plans. As a next-generation
TPA (Third Party Administrator) using SMART technology (deeplearning powered), Marpai’s mission is to save lives, improve lives, and
radically reduce the costs of healthcare for employers and plan
members.
CFO Compliance Guide 2019 | Paycor - New York- Long IslandAdam J. Brier
Top Concerns by Chief Financial Officers that impact revenues, margins and using benchmark analytics is critical for profit, and non-for-profit organizations.
In Canada, tax is paid at both federal and provincial (i.e. state) levels of government.
Both the federal government and most provincial governments provide funding for scientific and technological R&D through a system of tax credits.
The official title of this system of R&D tax credits is the Scientific Research & Experimental Development tax credit abbreviated SR&ED.
The SR&ED program is administrated by the Canada Revenue Agency abbreviated CRA.
All taxpayers anywhere in Canada are eligible to receive R&D tax credits at the federal level. Eligibility for R&D tax credits at the provincial level is predicated on two considerations; First the province must have an R&D credit and second, you must be a taxpayer in that province.
In addition to being done by a Canadian taxpayer, the R&D work must be done in Canada.
Marpai is an AI tech company revolutionizing the self-funded health plan
market representing over $1 trillion in health claims, $20 billion in
administrative fees, and 95 million Americans. Just as Netflix, Amazon,
Uber, and Tesla use artificial intelligence to transform and lead industry
sectors, Marpai (pronounced Mar-pay) is using deep learning, the most
advanced artificial intelligence, to transform health plan administration
for companies who self-fund their health plans. As a next-generation
TPA (Third Party Administrator) using SMART technology (deeplearning powered), Marpai’s mission is to save lives, improve lives, and
radically reduce the costs of healthcare for employers and plan
members.
CFO Compliance Guide 2019 | Paycor - New York- Long IslandAdam J. Brier
Top Concerns by Chief Financial Officers that impact revenues, margins and using benchmark analytics is critical for profit, and non-for-profit organizations.
Encoursa Webinar: How Government Contractors Qualify for the R&D Tax CreditRobert E Jones
The research tax credit is one of the most valuable credits available for a business. Many misconceptions associated with the research tax credit prevent companies from maximizing their benefit. One of the biggest misconceptions is government contracts do not qualify for the research tax credit because the tax code states, "funded research is excluded". In this course, you will learn more about the research tax credit and surrounding case law that explains how government contracts can qualify for R&D credit, the criteria needed and included expenses.
Encoursa Webinar: How Government Contracts Qualify for the R&D Tax CreditRobert E Jones
The research tax credit is one of the most valuable credits available for a business. Many misconceptions associated with the research tax credit prevent companies from maximizing their benefit. One of the biggest misconceptions is government contracts do not qualify for the research tax credit because the tax code states, "funded research is excluded". In this course, you will learn more about the research tax credit and surrounding case law that explains how government contracts can qualify for R&D credit, the criteria needed and included expenses.
5 things life sciences companies need to know about the R&D creditGrant Thornton LLP
Congress is deep in negotiations over the R&D credit, which represents one of the most important tax incentives for life sciences companies. What you need to know. More at: http://gt-us.co/1qUDh8T
Why record keeping is important for maximising R&D tax credit claimAlexander Clifford
To unlock the incredible opportunity of R&D tax credits for your innovative business, you need to provide various evidence to HMRC to strengthen your claim and prevent the risk of a time-consuming enquiry. Whether you're a small startup or a large enterprise, understanding the nuances of effective record-keeping can make all the difference in harnessing the incentives designed to fuel innovation and elevate your business to new heights. This article will guide you through the reasons why record keeping is vital for your R&D tax credit claim and provide practical guidelines on what to include in your records as you carry out your research and development or when you’re claiming retrospectively.
Which documents are required for submitting an R&D claimAlexander Clifford
Whether you’re a first-time R&D claimer, or you’ve previously claimed, it’s important to keep track of the latest regulations about the necessary documents for an R&D claim. The purpose of the documentation is to showcase your endeavours in contributing to the technological and scientific advancement in your industry. Listing the correct information about your trial and error attempts, and the costs involved, helps HMRC to reward you with the tax benefit you deserve for your endeavours. Let’s dive into the documentation you need for your upcoming R&D claim.
001 - Avoiding HMRC R&D tax relief inquiries Jumpstart UK
Deciphering which aspects of a company’s work are eligible for R&D tax relief is one of the most difficult aspects of an application.
At Jumpstart, we like sharing our expertise!
Working together with accountants, Jumpstart find and maximise the client’s eligibility while accountants utilise its tax benefit. We ALWAYS complement rather than compete.
Here are our recommendations for making successful, inquiry free claims...
Our team of R&D tax credit specialists has developed a comprehensive guide that serves as a vital resource for businesses aiming to capitalise on the potential of research and development tax relief. By delving into the intricacies of these credits, the guide offers valuable insights to diverse audiences, including entrepreneurs, business leaders, and decision makers. The eBook covers essential aspects such as eligibility criteria, qualifying R&D activities and costs, navigating the claim process, and more. It unravels complex tax incentives and empowers you with actionable insights to make well-informed decisions regarding your R&D tax claims.
Fund Your Innovation - SR&ED Tax Credits and other Government GrantsBoast Capital
So now that you’ve started a business and have everything figured out you’ve started to look at alternative financing options. The non-dilutive options are great but what are the options and how do you access this cash? We will walk you through the SR&ED tax incentive program and discuss IRAP, IDMTC and other government grants available to help you build your product(s).
Alex Popa presented the answers to the following questions for DevFestYVR on Feb 21:
-What you need to know about the SR&ED program.
-How the SR&ED program applies to product and process development in the real world.
-What does the SR&ED claim process look like – a detailed walkthrough.
-How can I make this source of funding more reliable?
-What are some of the government grants available to help lower the cost of building a product? A look at IRAP, IDMTC, and other sources of funding.
If your company spends money on improving its product, developing new products or improving processes you could be missing out on hundreds of thousands of dollars.
Substantial changes to SR&ED tax credits on the horizon . . . . . .
(17-Oct-2011) A six-member panel, appointed by the Canadian Federal Government, released its report on the efficacy of various economic-stimulus programs intended to increase private sector R&D and technological innovation.
BUDGET1Operating BudgetMonica AyresHCA 311 Health Ca.docxhartrobert670
BUDGET
1
Operating Budget
Monica Ayres
HCA 311: Health Care Financing and Information Systems
Kevin Hayes
July 13, 2015
Operating Budget
Before the manager or board accept the proposal for capital investment, there are a number of factors they should consider. The first factor to consider is the community need requirements (Herkimer, 1986). The health care needs of the community must be identified an then the capital investments selected which will best serve this need. In fact there is no use in internally selecting a capital project which management thinks the community needs, then trying to convince the citizenry that they need.
From the case provided, it is apparent that the move to expand the operations of the company is motivated by the fact that the company has not embarked on any serious capital investment plan for a period spanning over 6 years. This is a weak factor because it clearly indicates that the community need is not the main issue. The case further indicates that the company is facing severe competition from its rival in the Health Care market. This implies that the products are available from different and that there community members can still get products if they want from the competitors. Expanding is not a solution to this issue. In fact, if competition is what is forcing the company to seek plans to expand, then the manager or the board is less likely to accept the proposal.
Another factor to consider is marketability of the proposal (Herkimer, 1986). Based on the case provided, it is clear that there are many competitors in the market. Interestingly, the proposal intends to expand the enterprise so that the number of products produced increases. This is ridiculous because there is no need to increase the amount of products produced when it is clear that there are many competitors in the market. In fact, what the company should have done instead was to invest on technology to reduce the cost of production and hence lower the prices. This could enable the company compete well with competitors. Consequently, as far as marketability of proposed changes is concerned, the proposal is not strong.
The last factor to consider is urgency (Herkimer, 1986). Based on the case, there is no argument made to show that there is urgency or that the community needs the changes to be implemented urgently. This means that as far as urgency is concerned, the capital investment is not viable.
Reference
Top of Form
Herkimer, A. G. (1986). Understanding hospital financial management. Rockville, Md: Aspen Publishers.
Bottom of Form
CAPITAL INVESTMENT
1
Capital Investment Plan
Monica Ayres
HCA 311: Health Care Financing & Information Systems
Kevin Hayes
July 6, 2015
Capital Investment Plan
Abble Inc. is planning to undertake an expansionary Capital Investment process that will see the company’s operations and proceeds double hence cushioning the company’s going concern basis. The move to expand the operations of the company is ...
Claiming for R&D Tax Relief: DO YOU REALLY HAVE IT COVERED?Jumpstart UK
Claiming for R&D tax relief is a complex business and one that requires a broad range of knowledge, not only of the R&D being carried out, but also of the very comprehensive guidelines set out by HMRC.
While most companies have the first part covered – a thorough understanding of what they do – many find that the trickiest part of the claim process is understanding just what HMRC expects from them, resulting in two main issues - over claiming and being subjected to inquiry or under claiming and losing out on money. So does your manufacturing business have R&D tax relief claims covered? The following questions should reveal the true answer....
ERTC Funding
ERTCpro.com
Employee retention is a crucial element in the success of any organization. The ability to retain skilled and experienced employees not only helps maintain productivity levels but also ensures continuity in the business operations. However, with the current economic climate, many organizations are struggling to keep their workforce intact due to financial constraints.
To address this issue, governments across the globe have introduced measures such as employee retention tax credits (ERTC) to incentivize employers to retain their employees amid the pandemic.
The ERTC is a tax credit that provides financial relief for eligible employers who continue to pay their employees during periods of economic hardship caused by COVID-19. This tax credit was introduced by the Coronavirus Aid, Relief, and Economic Security (CARES) Act in March 2020 and has since been expanded and extended under subsequent legislation.
As an expert in ERTC tax credits, it is the duty of us at ERTCpro.com to educate employers on how they can take advantage of this program to retain their workforce while reducing their tax liability. In this article, we will explore the eligibility criteria, benefits, and application process for ERTC and provide insights on how organizations can maximize its potential for employee retention.
Overview Of The Employee Retention Tax Credit (ERTC)
The Employee Retention Tax Credit (ERTC) is a tax incentive program that was introduced to help businesses retain their employees during the COVID-19 pandemic. The ERTC provides eligible employers with a refundable tax credit of up to $5,000 per employee. This credit can be used to offset the employer's share of Social Security taxes.
A benefits analysis should be performed by eligible employers to determine if they qualify for the ERTC. To qualify, an employer must have experienced a significant decline in gross receipts or been forced to suspend operations due to a government order related to COVID-19. Additionally, employers must have maintained their workforce during the period in which the credit is being claimed.
The ERTC can provide much-needed support in these uncertain times.
Questions? See ERTCpro.com
Encoursa Webinar: How Government Contractors Qualify for the R&D Tax CreditRobert E Jones
The research tax credit is one of the most valuable credits available for a business. Many misconceptions associated with the research tax credit prevent companies from maximizing their benefit. One of the biggest misconceptions is government contracts do not qualify for the research tax credit because the tax code states, "funded research is excluded". In this course, you will learn more about the research tax credit and surrounding case law that explains how government contracts can qualify for R&D credit, the criteria needed and included expenses.
Encoursa Webinar: How Government Contracts Qualify for the R&D Tax CreditRobert E Jones
The research tax credit is one of the most valuable credits available for a business. Many misconceptions associated with the research tax credit prevent companies from maximizing their benefit. One of the biggest misconceptions is government contracts do not qualify for the research tax credit because the tax code states, "funded research is excluded". In this course, you will learn more about the research tax credit and surrounding case law that explains how government contracts can qualify for R&D credit, the criteria needed and included expenses.
5 things life sciences companies need to know about the R&D creditGrant Thornton LLP
Congress is deep in negotiations over the R&D credit, which represents one of the most important tax incentives for life sciences companies. What you need to know. More at: http://gt-us.co/1qUDh8T
Why record keeping is important for maximising R&D tax credit claimAlexander Clifford
To unlock the incredible opportunity of R&D tax credits for your innovative business, you need to provide various evidence to HMRC to strengthen your claim and prevent the risk of a time-consuming enquiry. Whether you're a small startup or a large enterprise, understanding the nuances of effective record-keeping can make all the difference in harnessing the incentives designed to fuel innovation and elevate your business to new heights. This article will guide you through the reasons why record keeping is vital for your R&D tax credit claim and provide practical guidelines on what to include in your records as you carry out your research and development or when you’re claiming retrospectively.
Which documents are required for submitting an R&D claimAlexander Clifford
Whether you’re a first-time R&D claimer, or you’ve previously claimed, it’s important to keep track of the latest regulations about the necessary documents for an R&D claim. The purpose of the documentation is to showcase your endeavours in contributing to the technological and scientific advancement in your industry. Listing the correct information about your trial and error attempts, and the costs involved, helps HMRC to reward you with the tax benefit you deserve for your endeavours. Let’s dive into the documentation you need for your upcoming R&D claim.
001 - Avoiding HMRC R&D tax relief inquiries Jumpstart UK
Deciphering which aspects of a company’s work are eligible for R&D tax relief is one of the most difficult aspects of an application.
At Jumpstart, we like sharing our expertise!
Working together with accountants, Jumpstart find and maximise the client’s eligibility while accountants utilise its tax benefit. We ALWAYS complement rather than compete.
Here are our recommendations for making successful, inquiry free claims...
Our team of R&D tax credit specialists has developed a comprehensive guide that serves as a vital resource for businesses aiming to capitalise on the potential of research and development tax relief. By delving into the intricacies of these credits, the guide offers valuable insights to diverse audiences, including entrepreneurs, business leaders, and decision makers. The eBook covers essential aspects such as eligibility criteria, qualifying R&D activities and costs, navigating the claim process, and more. It unravels complex tax incentives and empowers you with actionable insights to make well-informed decisions regarding your R&D tax claims.
Fund Your Innovation - SR&ED Tax Credits and other Government GrantsBoast Capital
So now that you’ve started a business and have everything figured out you’ve started to look at alternative financing options. The non-dilutive options are great but what are the options and how do you access this cash? We will walk you through the SR&ED tax incentive program and discuss IRAP, IDMTC and other government grants available to help you build your product(s).
Alex Popa presented the answers to the following questions for DevFestYVR on Feb 21:
-What you need to know about the SR&ED program.
-How the SR&ED program applies to product and process development in the real world.
-What does the SR&ED claim process look like – a detailed walkthrough.
-How can I make this source of funding more reliable?
-What are some of the government grants available to help lower the cost of building a product? A look at IRAP, IDMTC, and other sources of funding.
If your company spends money on improving its product, developing new products or improving processes you could be missing out on hundreds of thousands of dollars.
Substantial changes to SR&ED tax credits on the horizon . . . . . .
(17-Oct-2011) A six-member panel, appointed by the Canadian Federal Government, released its report on the efficacy of various economic-stimulus programs intended to increase private sector R&D and technological innovation.
BUDGET1Operating BudgetMonica AyresHCA 311 Health Ca.docxhartrobert670
BUDGET
1
Operating Budget
Monica Ayres
HCA 311: Health Care Financing and Information Systems
Kevin Hayes
July 13, 2015
Operating Budget
Before the manager or board accept the proposal for capital investment, there are a number of factors they should consider. The first factor to consider is the community need requirements (Herkimer, 1986). The health care needs of the community must be identified an then the capital investments selected which will best serve this need. In fact there is no use in internally selecting a capital project which management thinks the community needs, then trying to convince the citizenry that they need.
From the case provided, it is apparent that the move to expand the operations of the company is motivated by the fact that the company has not embarked on any serious capital investment plan for a period spanning over 6 years. This is a weak factor because it clearly indicates that the community need is not the main issue. The case further indicates that the company is facing severe competition from its rival in the Health Care market. This implies that the products are available from different and that there community members can still get products if they want from the competitors. Expanding is not a solution to this issue. In fact, if competition is what is forcing the company to seek plans to expand, then the manager or the board is less likely to accept the proposal.
Another factor to consider is marketability of the proposal (Herkimer, 1986). Based on the case provided, it is clear that there are many competitors in the market. Interestingly, the proposal intends to expand the enterprise so that the number of products produced increases. This is ridiculous because there is no need to increase the amount of products produced when it is clear that there are many competitors in the market. In fact, what the company should have done instead was to invest on technology to reduce the cost of production and hence lower the prices. This could enable the company compete well with competitors. Consequently, as far as marketability of proposed changes is concerned, the proposal is not strong.
The last factor to consider is urgency (Herkimer, 1986). Based on the case, there is no argument made to show that there is urgency or that the community needs the changes to be implemented urgently. This means that as far as urgency is concerned, the capital investment is not viable.
Reference
Top of Form
Herkimer, A. G. (1986). Understanding hospital financial management. Rockville, Md: Aspen Publishers.
Bottom of Form
CAPITAL INVESTMENT
1
Capital Investment Plan
Monica Ayres
HCA 311: Health Care Financing & Information Systems
Kevin Hayes
July 6, 2015
Capital Investment Plan
Abble Inc. is planning to undertake an expansionary Capital Investment process that will see the company’s operations and proceeds double hence cushioning the company’s going concern basis. The move to expand the operations of the company is ...
Claiming for R&D Tax Relief: DO YOU REALLY HAVE IT COVERED?Jumpstart UK
Claiming for R&D tax relief is a complex business and one that requires a broad range of knowledge, not only of the R&D being carried out, but also of the very comprehensive guidelines set out by HMRC.
While most companies have the first part covered – a thorough understanding of what they do – many find that the trickiest part of the claim process is understanding just what HMRC expects from them, resulting in two main issues - over claiming and being subjected to inquiry or under claiming and losing out on money. So does your manufacturing business have R&D tax relief claims covered? The following questions should reveal the true answer....
ERTC Funding
ERTCpro.com
Employee retention is a crucial element in the success of any organization. The ability to retain skilled and experienced employees not only helps maintain productivity levels but also ensures continuity in the business operations. However, with the current economic climate, many organizations are struggling to keep their workforce intact due to financial constraints.
To address this issue, governments across the globe have introduced measures such as employee retention tax credits (ERTC) to incentivize employers to retain their employees amid the pandemic.
The ERTC is a tax credit that provides financial relief for eligible employers who continue to pay their employees during periods of economic hardship caused by COVID-19. This tax credit was introduced by the Coronavirus Aid, Relief, and Economic Security (CARES) Act in March 2020 and has since been expanded and extended under subsequent legislation.
As an expert in ERTC tax credits, it is the duty of us at ERTCpro.com to educate employers on how they can take advantage of this program to retain their workforce while reducing their tax liability. In this article, we will explore the eligibility criteria, benefits, and application process for ERTC and provide insights on how organizations can maximize its potential for employee retention.
Overview Of The Employee Retention Tax Credit (ERTC)
The Employee Retention Tax Credit (ERTC) is a tax incentive program that was introduced to help businesses retain their employees during the COVID-19 pandemic. The ERTC provides eligible employers with a refundable tax credit of up to $5,000 per employee. This credit can be used to offset the employer's share of Social Security taxes.
A benefits analysis should be performed by eligible employers to determine if they qualify for the ERTC. To qualify, an employer must have experienced a significant decline in gross receipts or been forced to suspend operations due to a government order related to COVID-19. Additionally, employers must have maintained their workforce during the period in which the credit is being claimed.
The ERTC can provide much-needed support in these uncertain times.
Questions? See ERTCpro.com
Compensation Compliance for Federal Contractors: The Rules Have Changed!
10 Myths
1.
2. The Canadian government has come a far way since the long gone days of the abused SRTC (Scientific and
Research Tax Credit) program. Since 1985, the government has made available the SR&ED (Scientific Research
and Exploratory Development) program to effectively motivate an increase in industrial research and
exploratory development. This program provides tax credits which are worth up to 68.45% of the incremental
SR&ED spending and are refundable for companies that are at a pre-revenue stage. With considerable industry
collaboration, the program has been updated and modified over the last 20 years, to improve its effectiveness. It
appears that the program is now at a stage where it is working quite well. Nonetheless, given its long history,
there are quite a number of misconceptions about the program that may be deterring companies from filing an
SR&ED claim.
This article will discuss 10 common myths that may be preventing companies from taking advantage of the
program. As a prelude, it is important to note the 3 fundamental criteria for eligibility to file an SR&ED claim.
They are:
1. The work done must have been undertaken with the goal of achieving a technological
advancement
2. There must be uncertainty in the outcome of the project at the outset
3. The scientific method must have been employed in working through the project
These 3 criteria, in effect, become the 3 immutable laws of filing an SR&ED claim. With this basic
understanding, the following are the 10 myths which may steer companies astray.
1. You have to reveal your secrets
Filing an SR&ED claim is about demonstrating to the government that you have a valid claim, i.e. meeting the 3
immutable laws which constitute SR&ED and being able to support your claim. As such, the filing consists of a
top down presentation of your efforts. Going down to more detailed discussions is only necessary insofar as it is
needed to prove that you indeed meet the 3 fundamental criteria. As such, this means that it is not necessary to
explain the fundamental principles of your technology advancement as would be necessary in a patent filing for
example. As far as access to your specific information, the government has the strictest security in handling the
corporate documents themselves. Once your SR&ED filing has been received by your filing tax office, the
documents are transferred with special secure mailing to your CRA review office. Within the CRA office itself,
there is authorized and controlled access to the filing room itself. Rest assured, the government program is there
to provide real financial assistance to those that qualify under the program. Your technological advancements
remain completely private to your company.
2. It takes forever to get your claim approved
In the past it may have taken up to 18 months to get your file processed, but this is certainly not the recent past.
The government has made the necessary efforts to ensure that the processing times have come down to a point
where companies can make near term plans as to how they will use the money. This includes quite a sizable
technical staff who has the ability to fully grasp the essence of what you are presenting. In addition, the technical
staff are partnered with financial reviews in a joint approach. This then ensures that the claim review cannot get
bogged down in either aspect (i.e. technical or financial), as the reviewers are collaborating to ensure that the
review is efficient and timely. As for actual processing times, Canadian controlled private corporations (CCPC)
are given the highest priority. The government’s goal is to take a completed filing, with no missing or incomplete
information and have a cheque issued within 4 months.
3. Our work does not qualify because our business is not in science or technology
The SR&ED program is not for the exclusive domain of science and technology companies. The program is
focused on driving technological advancement regardless of what business you are in. Inherently, it means that
Quovis Consulting Corporation 2
3. you have to take some technical risks in coming up with technological advancements in how you run your
operations (i.e. processes) or in your product offering itself. The fact is that many businesses do this type of
activity in order to maintain a competitive position within their marketplace. An example of a non-technical
business that would qualify is a tomato grower who has experimented with ways to produce larger tomatoes.
4. There is a lot of work in setting-up formalized process in order to file an SR&ED claim
There are no special company processes that are necessary in order to file a claim. The government is primarily
concerned with your ability to support your claim and provide appropriate proof as to its validity. Both the claim
filing and claim support information are drawn from the processes that are native to your company. Many
supporting documents will stem from normal communication records such as meeting minutes or internal e-mails
which report the status of various projects. Ultimately, there does need to be sufficient level of records for the
claim to be approved. The work of filing is not in following some prescribed process but in extracting the
appropriate information to support qualifying technological advancements.
5. It is not worth the bother
Filing an SR&ED claim is well worth the bother for 2 reasons: (1) The tax credits are very significant and (2) The
tax credits are refundable for small companies. Without going through a detailed calculation, if we consider a
company that spends $100k on salaries to perform the SR&ED, the tax credit refund which a Canadian controlled
private corporation (CCPC) would receive is $68.48k (assuming a typical provincial participation). If the CCPC
had no taxable income or was at a pre-revenue stage, they would receive a refund in the full amount. Larger
corporations would receive amounts that are somewhat reduced from this but they are still quite significant. Now
you can think about this in many ways: you can do more SR&ED, you can hire better, you can expedite your
projects. No matter how you look at it, the SR&ED program has the ability to be a regular on-going source of
financing for you.
6. We don’t do research here and standard engineering and development does not qualify
It is a common misconception that engineering and development are just part of what a company needs to do and
would not qualify for an SR&ED tax credit. While this statement is technically correct, you must look at your
work from an SR&ED orientation. That is, you must first determine whether you have an advancement that meets
the 3 criteria as set down by the SR&ED program. If there is such an advancement, then supporting activities to
the SR&ED work would also qualify as valid SR&ED expenditures. Among other things, supporting activities
include standard engineering and development work if those activities are a necessary part of the SR&ED and
they would not otherwise have been incurred. An example of this would be the building of a custom test jig that is
necessary to test a prototype; alternately, the programming of a custom user-interface to test software that is
SR&ED.
7. Our claim was rejected so there is no point in continuing
While this might be true, as long as you are not beyond the time limit (18 months after fiscal year end), it is
important to review the reasons why it did not get approved. If at the heart of the matter you have achieved a
technological advancement, then it is a matter of ensuring that the claim is adequately prepared from both the
technical aspects and the financial aspects. Even though the government has a highly skilled technical staff in
order to understand what you have done, they are not experts in all of the various fields. Hence, at times their
judgment may be off. If you believe that you could prove your technological advancement in front of a group of
peers, then it is worth defending your claim, even if you have to provide what effectively amounts to “expert
witness testimony”. On the financial side of things, it is conceivable that you could be claiming costs in a different
way than has been done before, and that are justifiable for your project. If you can explain and prove why it needs
to be so, then do so. Remember, especially with your first claim, you are establishing a precedent for how your
future claims will be treated.
Quovis Consulting Corporation 3
4. 8. We contract out so we don’t have anything to claim
Whether you contract out or not, a claim for SR&ED is valid if it meets the 3 fundamental criteria for the overall
project. What is important to note is that the SR&ED cannot be claimed by both you and the contractor. It is
therefore important to make it clear in the contract agreement that the contractor will not own the SR&ED rights
to the work. In the case where the overall project produces a technological advancement and the parts of it that are
contracted out represent routine development work, it is still possible to claim these as they may form an essential
part of the overall SR&ED project. An example would be if you have a project which makes a technological
advance in a manufacturing process and the software portion of the work is contracted out. As long as the
software as integral and essential to the overall project, it can be claimed.
9. We already receive government assistance and are not able to claim SR&ED
It is correct to say that you will have to deduct the government assistance from the SR&ED claim which you are
submitting. This does not mean that you are not able to make the SR&ED claim at all. If there are projects that
meet the 3 fundamental SR&ED criteria, you are able to file a claim within the filing deadline, and there are still
benefits to doing so. If the SR&ED credits add up to an amount that exceeds the level of government assistance,
then you have a credit or refund that you obtain. Secondly, if at some point in the future, you are obliged to make
repayments to the government for the assistance, you can then begin to take back the SR&ED credits that were
previously held back. If you had not made an SR&ED within the filing deadline when the opportunity existed,
then you would lose out on this option.
10. Our project failed and therefore we would not qualify for SR&ED
Failure of the project is not part of the criteria for assessing whether a claim is valid. Your project must meet the 3
fundamental criteria to qualify and that is all. If anything, failure of your efforts clearly highlights the fact that
there was technical risk and that the outcome was uncertain. Failures and set-backs are in fact common on the
road to achieving technological advancement. In fact, it is the aversion to risk-bearing and failures that the
government is trying to alleviate. So, failure is perfectly alright and understood when it comes to making an
SR&ED claim.
So there you have it. By providing such strong incentives to those that are willing to undertake efforts to achieve
technological advancement, it eases the financial burden of progress. Furthermore, it entices more companies to
look for ways to strive for technological advancement. This in turn has great benefits for our overall knowledge
base and for the overall health and growth of our economy. Exactly what the government is after. So don’t
hesitate, put the myths behind you and look for ways in which you can take advantage of this excellent
government program today.
Alex Grgorinic is a management consultant with Quovis Consulting Corporation. His firm assists companies in
identifying and filing for the SR&ED tax credits. He can be reached at alexg@quovisconsulting.com or
905-271-7006.
Copyright: 2005 Quovis Consulting Corporation. All Rights Reserved.
Quovis Consulting Corporation 4